Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients.

@article{Cholongitas2015InterferonfreeRF,
  title={Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients.},
  author={E Cholongitas and Chrysoula Leonidas Pipili and G V Papatheodoridis},
  journal={World journal of gastroenterology},
  year={2015},
  volume={21 32},
  pages={9526-33}
}
The goal of therapy in chronic hepatitis C virus (HCV) infection is sustained virological response (SVR) which reflects HCV eradication. Treatment against HCV has dramatically improved with the recent availability of direct-acting antivirals (DAAs) including sofosbuvir, simeprevir, daclatasvir, ledipasvir/sofosbuvir, paritaprevir/ombitasvir and dasabuvir. Carefully selected combinations of these DAAs offer the potential for highly effective all-oral safe regimens even for patients with… CONTINUE READING